2025
SJR Q1
JCR Q1 · 14,5
OA
13 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Biomedical Science
- Yayıncı
- BioMed Central Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1021777014230127
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 3,601
- Quartile Q1
- H-Index 130
- Atıf/yayın 14,16
- Doküman (3y) 299
- Atıf (3y) 4.174
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 14,5
- 5Y JIF 13,2
- JCI 1,67
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry (medical) Q1
- Cell Biology Q1
- Clinical Biochemistry Q1
- Endocrinology, Diabetes and Metabolism Q1
- Medicine (miscellaneous) Q1
- Molecular Biology Q1
- Pharmacology (medical) Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Cell Biology | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,601 | 14,5 | 13,2 | 1,67 | Q1 | 130 |
| 2024 | Q1 | Q1 | 3,172 | 12,1 | 12 | 1,54 | Q1 | 120 |
| 2023 | Q1 | Q1 | 2,606 | 9 | 10,7 | 1,42 | Q1 | 120 |
| 2022 | Q1 | Q1 | 2,52 | 11 | 10,9 | 1,37 | Q1 | 120 |
| 2021 | Q1 | Q1 | 2,449 | 12,8 | 10,8 | 1,36 | Q1 | 120 |
| 2020 | Q1 | Q1 | 2,182 | 8,4 | 7,3 | 1,11 | Q1 | 120 |
| 2019 | Q1 | Q1 | 1,767 | 5,8 | 4,7 | 1,03 | Q2 | 120 |
| 2018 | — | Q1 | — | 5,2 | 4,1 | 0,93 | Q2 | — |
| 2017 | Q1 | Q2 | 1,302 | 3,5 | 3,3 | 0,75 | Q2 | 120 |
| 2016 | Q1 | Q2 | 1,221 | 2,8 | 2,9 | — | — | 120 |
| 2015 | Q1 | Q2 | 1,316 | 2,9 | 3,1 | — | — | 120 |
| 2014 | Q1 | Q2 | 1,381 | 2,8 | 2,9 | — | — | 120 |
| 2013 | Q1 | Q2 | 1,125 | 2,7 | 2,7 | — | — | 120 |
| 2012 | Q1 | Q2 | 0,931 | 2,5 | 2,3 | — | — | 120 |
| 2011 | Q2 | Q3 | 0,717 | 2 | 2 | — | — | 120 |
| 2010 | Q1 | Q3 | 0,761 | 2 | 2,1 | — | — | 120 |
| 2009 | — | Q3 | — | 2 | 2 | — | — | — |
| 2008 | — | Q3 | — | 2 | 2,1 | — | — | — |
| 2007 | — | Q2 | — | 2 | 2,1 | — | — | — |
| 2006 | — | Q3 | — | 1,7 | — | — | — | — |
| 2005 | — | Q3 | — | 2 | — | — | — | — |
| 2004 | — | Q3 | — | 1,6 | — | — | — | — |
| 2003 | — | Q2 | — | 1,9 | — | — | — | — |
| 2002 | — | Q2 | — | 2,3 | — | — | — | — |
| 2001 | — | Q2 | — | 1,8 | — | — | — | — |
| 2000 | — | Q2 | — | 1,8 | — | — | — | — |
| 1999 | — | Q3 | — | 1 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q1 | Q1 | 20/207 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 8/191 |
| 2024 | CELL BIOLOGY | SCIE | Q1 | Q1 | 21/204 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 9/195 |
| 2023 | CELL BIOLOGY | SCIE | Q1 | Q1 | 30/205 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 15/189 |
| 2022 | CELL BIOLOGY | SCIE | Q1 | Q1 | 27/191 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 13/136 |
| 2021 | CELL BIOLOGY | SCIE | Q1 | Q1 | 24/195 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 11/139 |
| 2020 | CELL BIOLOGY | SCIE | Q1 | Q1 | 38/195 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 15/140 |
| 2019 | CELL BIOLOGY | SCIE | Q1 | Q2 | 47/195 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q2 | 17/139 |
| 2018 | CELL BIOLOGY | SCIE | Q2 | Q2 | 49/193 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q2 | 20/136 |
| 2017 | CELL BIOLOGY | SCIE | Q2 | Q2 | 91/190 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 46/133 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 111/190 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 51/128 |
| 2015 | CELL BIOLOGY | SCIE | Q3 | — | 101/187 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 45/124 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 113/184 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 50/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 49/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 57/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 63/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 54/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 50/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 45/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 36/81 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 43/76 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 37/72 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 39/71 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 34/72 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 21/74 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 29/75 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/74 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 42/76 |